BioWorld - Thursday, January 2, 2025
See today's BioWorld
X

Upgrade your daily dose of biopharma and medtech news

Subscribe to BioWorld™ news services

See subscription options
To read the full story, subscribe or sign in.

Opting for Nasdaq, I-Mab files for $100M IPO in U.S.

Oct. 31, 2019
By David Ho
No Comments
HONG KONG – Shanghai-based I-Mab Biopharma Co. Ltd. has filed for an IPO in the U.S., seeking to raise up to $100 million.
BioWorld Financings